• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

ObjectiveHealth Secures Growth Investment to Expand Innovative Clinical Research Model

by Fred Pennic 01/29/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
What You Should Know:

ObjectiveHealth, a pioneer in integrated specialty research, today announced a strategic investment from Vitruvian Partners, a renowned global growth equity firm.

– This strategic investment will fuel ObjectiveHealth’s expansion and its mission to revolutionize clinical research by seamlessly integrating trials into the practices of community-based physicians.

Transforming Clinical Trials, One Patient at a Time:

ObjectiveHealth stands out with its innovative approach. They act as a bridge between pharmaceutical companies and patients, seamlessly integrating clinical trials into the existing workflows of specialty physicians. This is achieved through:

  • Proprietary AI technology: Leveraging patient electronic health record data and physician schedules, ObjectiveHealth’s AI efficiently identifies potential trial candidates, saving time and resources.
  • Streamlined trial management: Their platform simplifies trial workflow, providing physicians with tools to manage the process effectively.
  • Dedicated research coordinators: On-site coordinators ensure smooth trial execution and support both patients and physicians.
  • Community-based centers-of-excellence: By embedding trials within existing practices, ObjectiveHealth creates centers of excellence in specialty care, benefiting both patients and the research community.

Vitruvian Partners Fuels Growth:

Vitruvian’s investment recognizes ObjectiveHealth’s potential to disrupt the clinical research landscape. This funding will enable the company to:

  • Expand its network of partner practices: Reach a wider pool of patients and drive greater participation in vital clinical trials.
  • Further develop its AI technology: Enhance patient matching capabilities and streamline trial management processes.
  • Invest in research infrastructure: Strengthen its capabilities to conduct high-quality clinical research across diverse specialties.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |